Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriple Point Ve Regulatory News (TPV)

Share Price Information for Triple Point Ve (TPV)

Share Price is delayed by 15 minutes
Get Live Data
86.00    0.00 (0.00%)
Bid:
84.50
Ask:
87.50
Spread: 3.00 (3.55%)
Market Cap: £113.74m
TPV Live PriceLast checked at - London Stock Exchange

Intraday Triple Point Ve Share Chart

Issue of Supplementary Prospectus

27 Feb 2026 15:40

RNS Number : 7805U
Triple Point Venture VCT PLC
27 February 2026
 

27 February 2026

 

Triple Point Venture VCT plc

Issue of Supplementary Prospectus

The Board of Triple Point Venture VCT plc (the "Company") announces that a supplementary prospectus (the "Supplementary Prospectus") relating to the Company's offer for subscription to raise up to £10 million, with an over-allotment facility of up to £20 million (the "Offer"), in the 2025/2026 and 2026/2027 tax years, has been published today.

The Supplementary Prospectus refers to the decision of the Board of the Company to increase, due to strong investor demand, the size of the Offer to £10 million with a £35 million over-allotment facility.

A copy of the Supplementary Prospectus has been submitted to the Financial Conduct Authority and will shortly be available for inspection at the National Storage Mechanism, which is located at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

A copy of the prospectus relating to the Offer and the Supplementary Prospectus may be viewed on the Company's website at: www.triplepoint.co.uk.

 

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT:

Triple Point Investment Management LLP (Investment Manager)

Tel: 020 7201 8989

 Seb Wallace

 Jack Rose

 

The Company's LEI is 213800AOOAQA5XQDEA89

 

Further information on the Company can be found on its website 

https://www.triplepoint.co.uk/current-vcts/triple-point-venture-vct-plc/s2539/

 

NOTES:

The Company is a Venture Capital Trust incorporated in July 2010 and was established to fund small and medium sized enterprises. The Investment Manager is Triple Point Investment Management LLP.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPSEAFIWEMSEDE
Date   Source Headline
6th Jul 20267:00 amRNSAnnual Financial Report and Notice of AGM
3rd Jul 202611:56 amRNSIntention to Launch an Offer for Subscription
30th Jun 20263:35 pmRNSTotal Voting Rights
29th Jun 202612:52 pmRNSFinal Results for the year ended 28 February 2026
25th Jun 20264:51 pmRNSTransaction in Own Shares
30th Apr 20262:14 pmRNSTotal Voting Rights
10th Apr 20261:20 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20264:09 pmRNSTotal Voting Rights
31st Mar 20264:05 pmRNSResult of General Meeting
31st Mar 20261:00 pmRNSIssue of Equity and Total Voting Rights
24th Mar 202612:13 pmRNSIssue of Equity and Total Voting Rights
23rd Mar 20267:00 amRNSOffer for Subscription - over-allotment facility
20th Mar 20264:41 pmRNSTransaction in Own Shares
18th Mar 20264:36 pmRNSIssue of Equity and Total Voting Rights
4th Mar 20264:42 pmRNSPublication of a Circular
27th Feb 20264:29 pmRNSTotal Voting Rights
27th Feb 20263:40 pmRNSIssue of Supplementary Prospectus
18th Feb 20265:02 pmRNSProposed Increase in Size of Offer
16th Feb 20262:31 pmRNSISSUE OF EQUITY AND TOTAL VOTING RIGHTS
13th Feb 20264:34 pmRNSOffer for Subscription - over-allotment facility
2nd Feb 20267:00 amRNSNet Asset Value(s)
12th Jan 20267:00 amRNSDividend Declaration
31st Dec 202512:20 pmRNSTotal Voting Rights
31st Dec 202512:20 pmRNSTotal Voting Rights
19th Dec 20257:00 amRNSVenture Share Class Net Asset Value
16th Dec 202512:10 pmRNSIssue of Equity and Total Voting Rights
1st Dec 202512:06 pmRNSIssue of Equity and Total Voting Rights
28th Nov 20259:30 amRNSOffer for Subscription - over-allotment facility
21st Nov 20253:46 pmRNSTransaction in Own Shares
12th Nov 20257:00 amRNSResults for the six months ended 31 August 2025
11th Nov 202511:20 amRNSIssue of Equity and Total Voting Rights
3rd Nov 202510:33 amRNSTotal Voting Rights
14th Oct 202511:14 amRNSIssue of Equity and Total Voting Rights
29th Sep 20257:00 amRNSDividend Declaration
5th Sep 202512:30 pmRNSPublication of a Prospectus
1st Sep 20253:09 pmRNSTotal Voting Rights
8th Aug 20253:23 pmRNSTransaction in Own Shares
4th Aug 20257:00 amRNSIntention to Launch an Offer for Subscription
1st Aug 20259:21 amRNSTotal Voting Rights
31st Jul 20251:27 pmRNSIssue of Equity and Total Voting Rights
30th Jul 20254:29 pmRNSVenture Share Class Net Asset Value
22nd Jul 202511:36 amRNSResult of AGM
4th Jul 20254:28 pmRNSTransaction in Own Shares
4th Jul 20251:16 pmRNSIssue of Equity and Total Voting Rights
25th Jun 20252:44 pmRNSOffer for Subscription - over-allotment facility
24th Jun 20254:36 pmRNSAnnual Financial Report and Notice of AGM
24th Jun 202512:29 pmRNSPublication of Supplementary Prospectus
16th Jun 20257:00 amRNSFinal Results for the year ended 28 February 2025
1st May 20252:58 pmRNSTotal Voting Rights
8th Apr 202510:24 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.